CRISPR

CRISPR Price

CRISP

$0.00000952

38.64 % (1Y)

CRISPR price chart

CRISPR statistics

Price change (24h):

—

High (24h):

$0.00

Low (24h):

$0.00

Volume (24h):

$0

Market Cap:

$9.50K

All Time High:

$0.001214 99.22%

Nov 20, 2024

All Time Low:

$0.00000682 40%

Jun 5, 2026

Market data updated Nov 7, 2026, 12:00 AM UTC

About CRISPR

CRISPR (CRISPR) is a cryptocurrency launched in 2024. It straddles the meme coin sector and the nascent decentralized science (DeSci) movement, operating within the Solana ecosystem.

The project’s stated objective channels the precision of CRISPR-Cas9 gene editing technology toward aquatic organisms. It conceptualizes the delivery of Cas9 protein and synthetic guide RNA via nanoparticle or liposome carriers, dissolved in water, to induce targeted knockouts in genes governing pigmentation, fin morphology, and neural pathways. The intended result is a collection of visibly mutated specimens—fish with altered stripes, reduced melanin, or aberrant fin structures—demonstrating gene editing in a decentralized, community-observed fashion. This niche sits at the intersection of biohacking, ornamental aquaculture, and crypto-powered crowdfunding, bypassing traditional institutional research gatekeepers.

CRISPR operates on the Solana network. Its existence as a token leverages Solana’s high throughput and sub-second finality, though the asset itself inherits no on-chain governance or staking layers.

The token was minted through the Pump.fun launchpad, a mechanism that bootstraps liquidity via a bonding curve and migrates to an automated market maker once a fixed market cap threshold is reached. It conforms to the SPL token standard, with its smart contract address recorded on Solscan (AaV3hry7G3kL…). The Pump.fun ecosystem reliably spawns community-driven tokens that often eschew team allocations, though precise distribution details for CRISPR remain opaque.

The pseudonymous AquaticGenLab collective orchestrated the project, maintaining communication channels through a dedicated Telegram group, a Twitter account, and a website at aquaticgenlab.com. No named individuals have been disclosed. The token debuted on November 25, 2024, surfacing amid a wave of Solana-based DeSci meme experiments that repurpose on-chain speculation as a mechanism to fund and publicize niche scientific endeavors.

The mission orbits around democratizing genetic intervention in aquatic life. By focusing on traits like pigmentation and fin architecture, the project aims to produce repeatable, verifiable phenotypic outcomes that can be documented and shared, effectively turning a distributed network of observers into a citizen science cohort. This approach repositions CRISPR-Cas9 from a rarefied laboratory technique into a protocol for open-source wetware experimentation, where funding and visibility coalesce through token speculation.

The token itself performs no mechanical role within a protocol; it carries no rights to governance, fee distribution, or access to gene-editing services. Its function is entirely extrinsic. It serves as a speculative vehicle, its price reacting to narrative traction rather than utility. The AquaticGenLab team has not embedded any redemption or utility mechanisms into the SPL token, staying true to the minimalist meme coin format popularized by Pump.fun.

Holders transact CRISPR solely in secondary markets—initially on the bonding curve, then on the Raydium DEX after migration—seeking profits from volatility. There are no opportunities to stake, delegate, or use the token to influence research decisions. Liquidity providers supply the trading pair against SOL, but earn no protocol-level incentives.

CRISPR has a maximum supply of 1,000,000,000 tokens. Currently, 997,955,693.44 are in circulation. With a market capitalization of $9,191, CRISPR ranks #10,017 among all cryptocurrencies.

CRISPR Historical Price Data

Date Open Close High Low
$0.00000952 $0.00000952 $0.00000956 $0.00000948
$0.00000955 $0.00000952 $0.00000968 $0.00000947

Why is manual trading CRISPR a bad idea?

Manual CRISP trading
  • Miss perfect entry/exit
  • Emotional decisions
  • Huge time to monitor
Stoic AI
  • AI trades 24/7 automatically Catch every opportunity

  • Zero-emotion algorithm Disciplined strategy

  • Passive income Set & forget automation

$230M

cumulative aum

6 years

live trading track record

20k+

clients

2015

year of company foundation

Try Automated CRISP Trading

CRISPR FAQ

  • CRISPR (CRISPR) is a cryptocurrency launched in 2024. It straddles the meme coin sector and the nascent decentralized science (DeSci) movement, operating within the Solana ecosystem. CRISPR is a token on the Solana network.
  • CRISPR (CRISP) is trading at $0.00000952.
  • The market capitalization of CRISPR is $9.5K. It ranks #11373 among cryptocurrencies by market cap. 997.8M CRISP are in circulation. The maximum supply is 1B CRISP.
  • CRISPR reached its all-time high of $0.001214 on November 20, 2024. The current price is 99.2% below that peak. Its all-time low was $0.00000682 on June 5, 2026. Today's price is 39.6% above that low.
  • The CRISP price changed by -12.1% over 7 days, -27.2% over 30 days, and -38.6% over the past year.

Questions about Stoic AI itself are answered in the Stoic AI FAQ.

Disclaimer:

This website is operated by Cindicator Ltd., a Gibraltar private company. Cindicator is not a registered broker-dealer, investment adviser or regulated financial institution. Nothing on this page is financial, investment or legal advice, or an offer to buy or sell any cryptocurrency. Prices and market data come from third-party sources and are provided “as is”, without any warranty of accuracy or timeliness. Trading cryptocurrencies is highly speculative: you may lose all of your invested capital, and past performance is not indicative of future results. Access to Cindicator products may be restricted in some jurisdictions, and you are solely responsible for complying with the laws that apply to you. Cindicator is not liable for any loss arising from your use of this information. Please read our Terms of Use for further details. If you do not agree with these terms, please close this site.

Cookie Settings